Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PriCoTTF Study: A Phase I/II Study With TTFields Before and During Radiotherapy in Newly Diagnosed Glioblastoma

NCT07120620 is registered in ClinicalTrials.gov with Sied Kebir as lead sponsor.

NCT NCT07120620
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07120620 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PriCoTTF Study: A Phase I/II Study With TTFields Before and During Radiotherapy in Newly Diagnosed Glioblastoma
Lead sponsor
Sied Kebir
Phase
Phase 1/2
Overall status
Completed
Start date
June 25, 2019
Completion date
August 28, 2023
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma multiforme (gbm)